Viewing Study NCT00790192


Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2026-02-01 @ 7:36 PM
Study NCT ID: NCT00790192
Status: COMPLETED
Last Update Posted: 2016-03-17
First Post: 2008-11-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None SM-13496 View
None Latuda View
None Lurasidone View